Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Rueb Yuliya — Tyra Biosciences, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Rueb Yuliya

Rueb Yuliya

Vice President, Finance (PAO) at Tyra Biosciences, Inc. · on record since Apr 2, 2026

Insider trading activity of Rueb Yuliya

Transactions on record: 2; since May 7, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 7, 2026

Figures computed from official regulatory filings — methodology.

Companies where Rueb Yuliya has traded

Tyra Biosciences, Inc.2 tx · May 7, 2026

Track record of Rueb Yuliya

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Rueb Yuliya

Co-insiders of Rueb Yuliya

Alta Partners NextGen Fund II, L.P.Tyra Biosciences, Inc.
Alta Partners NextGen Fund II Management, LLCTyra Biosciences, Inc.
Ashar BhaveshTyra Biosciences, Inc.
Bensen DanielTyra Biosciences, Inc.
Boxer Asset Management Inc.Tyra Biosciences, Inc.
Boxer Capital, LLCTyra Biosciences, Inc.
Boxer Capital Management, LLCTyra Biosciences, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Canaan 2020+ Co-Investment L.P. Series 7Tyra Biosciences, Inc.

Canaan Partners 2020+ Co-Investment LLCTyra Biosciences, Inc.

Canaan Partners XI LLCTyra Biosciences, Inc.

Canaan XI L.P.Tyra Biosciences, Inc.

Chen BihuaTyra Biosciences, Inc.

CHEN ISANTyra Biosciences, Inc.

Cormorant Asset Management, LPTyra Biosciences, Inc.

Cormorant Global Healthcare Master Fund, LPTyra Biosciences, Inc.

Cormorant Private Healthcare Fund III LPTyra Biosciences, Inc.

Dable Habib JTyra Biosciences, Inc.

Davis Aaron I.Tyra Biosciences, Inc.

Fawaz Ali D.Tyra Biosciences, Inc.

Fuhrman AlanTyra Biosciences, Inc.

Gulfo Adele M.Tyra Biosciences, Inc.

Harris ToddTyra Biosciences, Inc.

Healy John StephenTyra Biosciences, Inc.

Hudkins Robert L.Tyra Biosciences, Inc.

Hudson Peter ATyra Biosciences, Inc.

JANNEY DANIELTyra Biosciences, Inc.

KAPLAN GILLATyra Biosciences, Inc.

Kjellson Nina STyra Biosciences, Inc.

Kolchinsky PeterTyra Biosciences, Inc.

LEWIS JOSEPHTyra Biosciences, Inc.

McCracken MelissaTyra Biosciences, Inc.

Moran SusanTyra Biosciences, Inc.

MORE ROBERT JTyra Biosciences, Inc.

MVA Investors, LLCTyra Biosciences, Inc.

Patel Piyush R.Tyra Biosciences, Inc.

RA Capital Biotech Fund LPTyra Biosciences, Inc.

RA CAPITAL MANAGEMENT, LLCTyra Biosciences, Inc.

RA Capital Nexus Fund, L.P.Tyra Biosciences, Inc.

Rothenberg Stephen MichaelTyra Biosciences, Inc.

Shah Rajeev M.Tyra Biosciences, Inc.

Simson JakeTyra Biosciences, Inc.

Subramony SiddarthTyra Biosciences, Inc.

Swanson Ronald V.Tyra Biosciences, Inc.

Tada HiroomiTyra Biosciences, Inc.

van den Boom EstherTyra Biosciences, Inc.

Verjee RehanTyra Biosciences, Inc.

Warner Douglas JTyra Biosciences, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Tyra Biosciences, Inc.	May 7, 2026	Award	8,333	0.00 USD	$0	SEC
Tyra Biosciences, Inc.	May 7, 2026	AwardD	28,000	0.00 USD	$0	SEC